หน้าหลัก

ManuscriptHeart Rhythm. Author manuscript; obtainable in PMC 2017 February 01.Published in final ManuscriptHeart Rhythm. Author manuscript; available in PMC 2017 February 01.Published in final edited type as: Heart Rhythm. 2016 February ; 13(two): e39 49. doi:ten.1016/j.hrthm.2015.12.001.Author Manuscript Author Manuscript Author Manuscript Author ManuscriptProceedings from Heart Rhythm Society's Emerging Technologies Forum:Boston, MA, May possibly 12, 2015 Emily P. Zeitler, MD*, Sana M. Al-Khatib, MD, MHS, FHRS*, David Slotwiner, MD, FHRS, Uday N. Kumar, MD^, Paul Varosy, MD, FHRS, David R. Van Wagoner, PhD, FHRS? Gregory M. Marcus, MD, FHRS#, Fred M. Kusumoto, MD, FHRS**, and Laura Blum, MA*DukeClinical Research Institute Duke University Hospital, Durham NC Program, Stanford University, Stanford CA^Biodesign WeillCornell Health-related College, New York, NY of Colorado Anschutz Healthcare Campus, Aurora, CO Clinic Lerner College of Medicine of Case Western Study University, Cleveland, of California San Francisco, San Francisco, CAUniversity levelandOH#University **Mayo HeartClinic, Jacksonville, Florida Rhythm Society, Washington, DCAbstractPhysicians are in a great position to considerably contribute to healthcare device innovation, but the process of bringing an concept for the bedside is complex. To begin to address these perceived barriers, the Heart Rhythm Society (HRS) convened a forum of stakeholders in healthcare device innovation in conjunction using the 2015 HRS Scientific Sessions. The forum facilitated open discussion about healthcare device innovation, such as obstacles to doctor involvement and achievable options. This report is primarily based around the themes that emerged. Initial, doctor innovators have to take an organized method to identifying unmet clinical desires and prospective options. Second, substantial funds, generally secured through solicitation for investment, are typically expected to achieve meaningful progress building an idea into a device. Third, preparing for regulatory requirements from the U.S. Meals Drug Administration (FDA) and Centers for Medicare and Medicaid Solutions (CMS) is crucial. Additionally to these difficulties, intellectual house and overall trends in wellness care, including international markets, are critically relevant considerations for the physician innovator. Importantly, there are numerous methods in which specialist societies canCorresponding Author: Emily P. Zeitler, MD, 2301 Erwin Rd, DUMC 3845, Durham NC 27710, [email protected], T ?919-684-8111, F ?919-681-9842. Developed in partnership with and endorsed by the Heart Rhythm Society (HRS). Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our consumers we are giving this early version from the manuscript. The manuscript will undergo copyediting, typesetting, and assessment of your resulting proof prior to it's published in its final citable form. Please note that throughout the production approach errors can be found which could influence the content material, and all legal disclaimers that apply towards the journal pertain.Zeitler et al.Pageassist doctor innovators to navigate the complex healthcare device innovation landscape, bring clinically meaningful devices to marketplace additional promptly, and eventually increase patient care. These efforts Trametinib Autophagy include facilitating interaction among potential collaborators through scientific meetings along with other gatherings; collecting, evaluating, and disseminating state-of-the-art scientific facts; and representing the interests of members in interactions with regulator.